ArticleFrontiers in immunology2024

The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy.

Di Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.